Roche - IMPACT study shows longer Valcyte treatment provides better protection against cytomegalovirus (CMV) disease
Links shared publicly online about this topic.
- 2,001total visits
Roche - IMPACT study shows longer Valcyte treatment provides better protection against cytomegalovirus (CMV) disease
Roche - IMPACT study shows longer Valcyte treatment provides better protection against cytomegalovirus (CMV) disease
View full resource at roche.com
Tags: Disease and Condition
Most Recently Shared on June 1, 2009 at 6:42 pm By:
IMPACT study shows longer Valcyte treatment provides better protection against cytomegalovirus (CMV) disease http://tinyurl.com/mnxkfs
Advertisement
